CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?--NEJM April 2020
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Release Date: 10/05/2022
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
π§ Dr RR Baliga's Got Knowledge Doc' PODKASTS for Physicians: on 'Hypertension in the Cardio-Oncology Clinic' . Not Medical Advice or Opinion
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Door-to-Guideline Directed Medical Therapy Time & Door to Max Dose GDMT Time for Heart Failure
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
π§Β Transthyretin (TTR) Amyloid: "Hot-off-the-Press Dr RR Baliga "Got Knowledge Doc" PodKast"
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Dr RR Baliga's Internal Medicine Podcast for Physicians: MUST KNOW FACTs about Asthma
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
from the chapter
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
info_outline
Dr. Baliga's 'Got Knowledge Doc?' PODKASTS
Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Statistics.
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Head & Neck Malignancies -3 (Summary)
info_outlineDr. Baliga's 'Got Knowledge Doc?' PODKASTS
Head & Neck Malignancies -2
info_outlineDr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians| CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?-NEJM April 2020 | Not Medical Advice or Opinion
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer N Engl J Med 2020; 382:1599-1607
- Anticoagulant Therapy for Venous Thromboembolism in Cancer N Engl J Med 2020; 382:1650-1652
- Tukaye DN, Brink H, Baliga R. Venous thromboembolism in cancer patients: risk assessment, prevention and management. Future Cardiol. 2016;12(2):221β235. doi:10.2217/fca.15.87
- Arcopinto M, Cella CA, Wesolowski R, et al. Primary prevention of cancer-related thrombosis: special focus on ambulatory patients. Int J Cardiol. 2014;173(3):583β584. doi:10.1016/j.ijcard.2014.03.109